US envoy, Novovax CEO hail role played by India and SII during COVID-19 pandemicThe delegates noted the critical role played by US-India cooperation in addressing the COVID-19 pandemic and other global health challenges...
Covovax approval to strengthen immunization efforts in India, lower and middle income countries, says SIIHe was responding to Union Health Minister Mansukh Mandaviya's announcement that the Central Drug Authority, the Central Drugs Standard Con...
Serum Institute of India hopes to launch Novavax Covid-19 vaccine for children in six monthsThe Novavax shot, which the world's largest producer of vaccines calls Covovax, has shown good results in trials in children aged three and...
Covovax nod expected by January, data to be submitted soon, says SII ChiefThe drug regulator had earlier asked the company - which had applied for emergency use authorisation (SII) for Covovax in August - to submi...
Serum Institute manufacturing first batch of Covovax COVID-19 vaccine, says Adar PoonawallaIn March this year, Poonawalla had said that the clinical trials of Covovax vaccine have begun in India and the company hopes to launch it ...
Relief for Serum Institute of India as US lifts curbs on vaccine inputs“This policy change will hopefully increase the supply of raw material globally and to India, boosting our vaccine production capacity and ...
Serum’s launch of Novavax shot in India may face delayAdar Poonawalla had complained in the past that the manufacturing of the Novavax vaccine was getting delayed due to a shortage of raw mater...
Covovax trials begin in India, hope to launch it by Sept 2021: Adar PoonawallaIn August 2020, American vaccine company Novavax, Inc had announced a licence agreement with SII for the development and commercialisation ...
GAVI inks pact with Serum Institute of India, Novavax for Covid-19 vaccine supplyThe Novavax vaccine has shown 90% efficacy in phase 3 clinical trials in the UK that enrolled more than 15,000 participants aged 18-84 year...
Serum Institute of India plans to launch Covovax by June: Adar PoonawallaSII CEO Adar Poonawalla said on Saturday that its partnership for a Covid-19 vaccine with Novavax has shown excellent efficacy results. "We...
India's Serum Institute expects WHO emergency approval for AstraZeneca shot soon"The emergency use licensure from the WHO (World Health Organization) should be available and coming through in the next week or two, hopef...
Serum Institute to price Covid-19 vaccine at $3 per dose for India and lower middle income nationsAs part of the agreement SII will also get upfront capital of $150 mn via the Bill and Melinda Gates Foundation to help the company increas...
Serum Institute inks deal to produce US-based biotech firm Novavax’s Covid vaccineThe Serum Institute of India (SII) will buy the vaccine components from Novavax and the two companies will equally split the revenue from t...
Indian entrepreneur’s stake in US vaccine company soars to Rs 400 croreNovavax calls itself a late-stage biotechnology company. Its Covid-19 vaccine candidate was developed using the company’s recombinant nanop...
Serum Institute owner sells Czech unit to US coThe Cyrus Poonawalla Group, owner of world’s largest vaccine manufacturer Serum Institute of India, has sold its Czech Republic-based Praha...
- Gujarat gearing up with latest swine-flu vaccine
While Gujarat’s chief minister Narendra Modi is down with Swine Flu, the state will see a swine flu vaccine being developed using the most ...
Novavax-Cadila to conduct swine flu clinical trials hereUS-based vaccine maker Novavax, that is developing a vaccine for swine flu, will conduct a major portion of the clinical trials in India.